Synergistic Glaucoma Treatment System

A novel system integrating visible and infrared ultrashort laser pulses with AI, IoT, blockchain, and nanomaterials for enhanced glaucoma treatment outcomes and personalized care.

The original patent disclosed methods for treating glaucoma using visible and infrared ultrashort laser pulses. However, these methods had limitations in terms of real-time monitoring, data tracking, and personalized treatment. The new inventive concept addresses these limitations by combining the original laser pulse technology with AI-powered OCT, IoT-enabled sensors, blockchain-based data storage, and nanomaterial-enhanced probes.

The synergistic glaucoma treatment system consists of four primary components: 1) a visible and infrared ultrashort laser pulse source; 2) an AI-powered OCT system for real-time monitoring of tissue removal; 3) a blockchain-based data storage module for secure tracking of treatment outcomes; and 4) IoT-enabled sensors for generating a 3D model of the patient's eye. The system operates by first generating a 3D model of the patient's eye using IoT-enabled sensors. Then, the AI-powered OCT system identifies optimal treatment sites, and the ultrashort laser pulses are directed to these sites using a robotic arm controlled by a neural network. The blockchain-based data storage module ensures secure tracking of treatment outcomes, enabling personalized treatment recommendations and predictive analytics.

The new inventive concept combines the original laser pulse technology with AI, IoT, blockchain, and nanomaterials in a novel and non-obvious way, providing enhanced glaucoma treatment outcomes and personalized care. The use of AI-powered OCT for real-time monitoring, IoT-enabled sensors for 3D modeling, and blockchain-based data storage for secure tracking of treatment outcomes are all new and inventive aspects of the system.

Alternative embodiments of the inventive concept could include the use of different AI algorithms for predictive analytics, various IoT devices for tracking intraocular pressure, or different nanomaterials for enhancing probe performance. Additionally, the system could be adapted for use in other ophthalmic surgical procedures, such as cataract removal or retinal detachment repair.

The synergistic glaucoma treatment system has significant commercial potential in the ophthalmic surgery market, particularly in the areas of glaucoma treatment and personalized medicine. The system's ability to provide enhanced treatment outcomes, real-time monitoring, and secure data tracking makes it an attractive solution for healthcare professionals and patients alike.